Wordt geladen...
Preferences for health outcomes associated with Group A Streptococcal disease and vaccination
BACKGROUND: A 26-valent Group A Streptococcus (GAS) vaccine candidate has been developed that may provide protection against pharyngitis, invasive disease and rheumatic fever. However, recommendations for the use of a new vaccine must be informed by a range of considerations, including parents'...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2848145/ https://ncbi.nlm.nih.gov/pubmed/20226042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7525-8-28 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|